Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 305

Pulmonx inhales $66m

Posco-backed medical device developer Pulmonx has added $66m to its coffers thanks to a consortium led by Ally Bridge and secured an additional $17m to refinance a debt facility.

May 6, 2020

Praxis Precision pinpoints $100m

Novo Holdings has joined the early-stage consortium of Praxis Precision, a gene therapy business co-founded by faculty from Columbia and Melbourne universities.

May 6, 2020

Medable mediates $25m

PPD has backed clinical trial preparation software developer Medable as an existing investor having also partnered the business to launch a telemedicine-based clinical trial product last year.

May 6, 2020

Boohee sweeps series C capital

The food and nutrition business picked up backers including Fosun International and existing investor Qualcomm Ventures after earlier rounds in 2011 and 2014.

May 6, 2020

Daily deal net: May 5, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

May 5, 2020

CVC in the Time of Coronavirus: Jon Eide and Dusty Lieb, Echo…

COO Jon Eide and partner Dusty Lieb have spoken to GCV about the balance between pursuing more attractive valuations while dealing with differing expectations from its healthtech portfolio.

May 5, 2020

Lenovo lays on series B funding for HGZ Medical

The computer manufacturer's corporate venturing unit backed a $14.2m round for medical robot developer HGZ Medical that comes after the latter's series A round in March 2019.

May 5, 2020

Daily deal net: May 4, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

May 4, 2020

Iliev takes the helm at NetScientific

EMV Capital managing director Ilian Iliev has replaced Ian Postlethwaite as CEO of NetScientific on a part-time basis.

May 4, 2020

Kurma sets the stage for $175m fund

Life sciences-focused venture firm Kurma Partners has secured Servier Laboratories for a third fund dedicated to early and incubation-stage therapeutics companies.

May 4, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here